Title of Invention

PYRIMIDINE COMPOUNDS

Abstract This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
Full Text

Documents:

2096-mumnp-2007-abstract.doc

2096-mumnp-2007-abstract.pdf

2096-MUMNP-2007-ANNEXURE A(30-5-2012).pdf

2096-MUMNP-2007-ANNEXURE A(4-5-2012).pdf

2096-MUMNP-2007-ANNEXURE B(30-5-2012).pdf

2096-MUMNP-2007-ANNEXURE B(4-5-2012).pdf

2096-MUMNP-2007-AU DOCUMENT(25-6-2012).pdf

2096-MUMNP-2007-CLAIMS(AMENDED)-(11-7-2012).pdf

2096-MUMNP-2007-CLAIMS(AMENDED)-(20-6-2012).pdf

2096-MUMNP-2007-CLAIMS(AMENDED)-(30-11-2011).pdf

2096-MUMNP-2007-CLAIMS(AMENDED)-(30-5-2012).pdf

2096-MUMNP-2007-CLAIMS(AMENDED)-(4-5-2012).pdf

2096-MUMNP-2007-CLAIMS(MARKED COPY)-(30-5-2012).pdf

2096-MUMNP-2007-CLAIMS(MARKED COPY)-(4-5-2012).pdf

2096-mumnp-2007-claims.doc

2096-mumnp-2007-claims.pdf

2096-MUMNP-2007-CORRESPONDENCE(11-7-2012).pdf

2096-mumnp-2007-correspondence(12-2-2008).pdf

2096-MUMNP-2007-CORRESPONDENCE(15-5-2009).pdf

2096-MUMNP-2007-CORRESPONDENCE(2-3-2012).pdf

2096-MUMNP-2007-CORRESPONDENCE(20-6-2012).pdf

2096-MUMNP-2007-CORRESPONDENCE(23-4-2012).pdf

2096-MUMNP-2007-CORRESPONDENCE(25-6-2012).pdf

2096-MUMNP-2007-CORRESPONDENCE(3-4-2009).pdf

2096-MUMNP-2007-CORRESPONDENCE(4-5-2012).pdf

2096-mumnp-2007-correspondence-others.pdf

2096-mumnp-2007-correspondence-received.pdf

2096-mumnp-2007-declaration(17-1-2008).pdf

2096-mumnp-2007-description (complete).pdf

2096-mumnp-2007-form 1(17-1-2008).pdf

2096-MUMNP-2007-FORM 1(2-3-2012).pdf

2096-MUMNP-2007-FORM 1(30-3-2009).pdf

2096-mumnp-2007-form 13(30-3-2009).pdf

2096-MUMNP-2007-FORM 18(15-5-2009).pdf

2096-mumnp-2007-form 2(title page)-(complete)-(10-12-2007).pdf

2096-mumnp-2007-form 26(17-1-2008).pdf

2096-mumnp-2007-form 3(17-1-2008).pdf

2096-MUMNP-2007-FORM 3(25-6-2012).pdf

2096-MUMNP-2007-FORM 3(30-11-2011).pdf

2096-mumnp-2007-form 5(17-1-2008).pdf

2096-mumnp-2007-form-1.pdf

2096-mumnp-2007-form-2.doc

2096-mumnp-2007-form-2.pdf

2096-mumnp-2007-form-3.pdf

2096-mumnp-2007-form-5.pdf

2096-mumnp-2007-form-pct-isa-220.pdf

2096-mumnp-2007-form-pct-isa-237.pdf

2096-MUMNP-2007-OTHER DOCUMENT(30-5-2012).pdf

2096-mumnp-2007-pct-search report.pdf

2096-MUMNP-2007-PETITION UNDER RULE-137(2-3-2012).pdf

2096-MUMNP-2007-PETITION UNDER RULE-137(30-11-2011).pdf

2096-MUMNP-2007-POWER OF AUTHORITY(30-3-2009).pdf

2096-MUMNP-2007-REPLY TO EXAMINATION REPORT(19-10-2011).pdf

2096-MUMNP-2007-REPLY TO EXAMINATION REPORT(30-11-2011).pdf

2096-MUMNP-2007-REPLY TO HEARING(30-5-2012).pdf

2096-mumnp-2007-wo international publication report(10-12-2007).pdf

abstract1.jpg


Patent Number 253338
Indian Patent Application Number 2096/MUMNP/2007
PG Journal Number 29/2012
Publication Date 20-Jul-2012
Grant Date 13-Jul-2012
Date of Filing 10-Dec-2007
Name of Patentee TAIGEN BIOTECHNOLOGY CO., LTD.
Applicant Address 7F, 138 SHIN MING RD. NEIHU DIST., TAIPEI, TAIWAN 114.
Inventors:
# Inventor's Name Inventor's Address
1 CHENG-KUNG CHOU NO. 68, LANE 165 MINSIANG ST. HSINCHU CITY, 300.
2 MING-CHEN CHOU 1F, NO.5, ALLEY 71, LANE 50, WUFENG RD., BAANCHAYU CITY, TAIPEI.
3 CHI FENG-YEN NO. 44, SEC. 1, JHONGSHAN RD. SANJHIH TOWNSHIP, TAIPAEI 252.
4 CHEN-TSO TSENG NO. 4, NANHUA RD., CHAOJHOU TOWNSHIP, PINGTUNG COUNTY TAIPEI, 920.
5 CHIEN-HUANG WU 8F, NO. 36-1, LANE 118, YI-AN ROAD, JHOHNHE CITY TAIPEI COUNTY, 235.
6 YING-HUEY HUANG 62-91 FU-HSING ROAD, FU-HSING COUNTY, CHANGHUA, 506.
7 SHU-JEN CHEN 8 ROSEMARY AVENUE, BUFFALO, NY 14216.
8 CHI-HSIN RICHARD KING 1191 SESSIONS DRIVE, CENTERVILLE, OH 45459.
PCT International Classification Number A61K31/5377
PCT International Application Number PCT/US2006/022975
PCT International Filing date 2006-06-13
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 60/690,267 2005-06-14 U.S.A.
2 60/798,596 2006-05-08 U.S.A.